| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 12.00B | 12.75B | 11.82B | 11.09B | 10.80B | 10.54B |
| Gross Profit | 6.17B | 6.55B | 6.08B | 5.71B | 5.45B | 5.23B |
| EBITDA | 4.12B | 4.33B | 4.08B | 3.83B | 3.62B | 3.53B |
| Net Income | 2.35B | 2.69B | 2.19B | 1.86B | 1.76B | 1.73B |
Balance Sheet | ||||||
| Total Assets | 16.69B | 20.61B | 17.08B | 16.71B | 14.74B | 14.36B |
| Cash, Cash Equivalents and Short-Term Investments | 4.02B | 4.17B | 4.53B | 6.95B | 6.27B | 5.17B |
| Total Debt | 985.00M | 1.83B | 1.81B | 1.81B | 1.95B | 2.40B |
| Total Liabilities | 3.70B | 4.90B | 4.21B | 4.48B | 4.16B | 4.62B |
| Stockholders Equity | 12.99B | 15.71B | 12.87B | 12.23B | 10.58B | 9.74B |
Cash Flow | ||||||
| Free Cash Flow | 663.00M | 3.06B | 2.70B | 2.85B | 2.56B | 2.84B |
| Operating Cash Flow | 686.00M | 3.34B | 2.84B | 2.98B | 2.61B | 2.90B |
| Investing Cash Flow | -823.00M | -1.77B | -2.45B | -553.00M | 222.00M | -2.26B |
| Financing Cash Flow | -648.00M | -1.93B | -2.82B | -1.75B | -1.74B | -1.69B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥119.62B | 9.20 | ― | 2.85% | 5.08% | -5.14% | |
72 Outperform | ¥1.06T | 10.73 | ― | 3.37% | 3.13% | 48.43% | |
70 Outperform | ¥35.45B | 13.87 | ― | 2.60% | 7.83% | 23.96% | |
68 Neutral | ¥31.80B | 8.57 | ― | 4.66% | -25.43% | 4.30% | |
64 Neutral | ¥392.57B | 11.14 | ― | 3.62% | 17.52% | -27.48% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
58 Neutral | ¥40.39B | 6.79 | ― | 3.90% | 53.30% | 35.91% |